Information Provided By: 
Fly News Breaks for September 20, 2019
MMSI
Sep 20, 2019 | 07:17 EDT
Canaccord analyst Jason Mills lowered his price target on Merit Medical to $37 from $53 ahead of Q3 results which he admits could be rocky in the near-term. The analyst said his checks show that many of the headwinds that lead to poor Q2 results, remain in the current quarter. He also believes the headwinds may last a few quarters before trends show improvement. Mills maintained his Buy rating on Merit Medical shares.
News For MMSI From the Last 2 Days
There are no results for your query MMSI
